Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2017, Article ID 3498368, 8 pages
https://doi.org/10.1155/2017/3498368
Research Article

Calcium Phosphate Product Is Associated with Subclinical Carotid Atherosclerosis in Type 2 Diabetes

1Health Sciences Research Institute Germans Trias i Pujol, Camí de les Escoles S/N, 08916 Badalona, Spain
2Department of Endocrinology and Nutrition, Health Sciences Research Institute and University Hospital Germans Trias i Pujol, Carretera Canyet S/N, 08916 Badalona, Spain
3Biomedical Research Institute of Lleida, University of Lleida, Rovira Roure 80, 25198 Lleida, Spain
4Biostatistics and Epidemiology Unit, Biomedical Research Institute of Lleida, University of Lleida, Rovira Roure 80, 25198 Lleida, Spain
5CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
6Epidemiology and Public Health, Universitat Internacional de Catalunya, Sant Cugat, Spain
7Unitat de Suport a la Recerca Barcelona, Institut Universitari d’Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Barcelona, Spain
8Department of Laboratory Medicine, University Hospital Arnau de Vilanova, Rovira Roure 80, 25198 Lleida, Spain
9Department of Endocrinology and Nutrition, University Hospital Arnau de Vilanova, Rovira Roure 80, 25198 Lleida, Spain
10Unitat de Deteccio i Tractament de Malalties Aterotrombotiques, University Hospital Arnau de Vilanova, Lleida, Spain
11Department of Nephrology, University Hospital Arnau de Vilanova, Lleida, Spain

Correspondence should be addressed to Didac Mauricio; moc.liamg@oiciruamcadid

Received 3 March 2017; Revised 17 June 2017; Accepted 11 July 2017; Published 3 August 2017

Academic Editor: Andrea Flex

Copyright © 2017 Anna Ramírez-Morros et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Cosson, J. R. Attali, and P. Valensi, “Markers for silent myocardial ischemia in diabetes. Are they helpful?” Diabetes & Metabolism, vol. 31, no. 4, pp. 205–213, 2005. View at Google Scholar
  2. P. M. Clarke, A. M. Gray, A. Briggs et al., “A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68),” Diabetologia, vol. 47, no. 10, pp. 1747–1759, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Seshasai and S. Kaptoge, “Diabetes mellitus, fasting glucose, and risk of cause-specific death,” New England Journal of Medicine, vol. 364, no. 9, pp. 829–841, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Orasanu and J. Plutzky, “The pathologic continuum of diabetic vascular disease,” Journal of the American College of Cardiology, vol. 53, 5 Supplement, pp. S35–S42, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Alonso, A. Traveset, E. Rubinat et al., “Type 2 diabetes-associated carotid plaque burden is increased in patients with retinopathy compared to those without retinopathy,” Cardiovascular Diabetology, vol. 14, no. 1, p. 33, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Vigili de Kreutzenberg, G. P. Fadini, S. Guzzinati et al., “Carotid plaque calcification predicts future cardiovascular events in type 2 diabetes,” Diabetes Care, vol. 38, no. 10, pp. 1937–1944, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Inaba, J. A. Chen, and S. R. Bergmann, “Carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: a meta-analysis,” Atherosclerosis, vol. 220, no. 1, pp. 128–133, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. S. I. Syed Ikmal, H. Zaman Huri, S. R. Vethakkan, and W. A. Wan Ahmad, “Potential biomarkers of insulin resistance and atherosclerosis in type 2 diabetes mellitus patients with coronary artery disease,” International Journal of Endocrinology, vol. 2013, Article ID 698567, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. H. F. Deluca, “Overview of general physiologic features and functions of vitamin D,” The American Journal of Clinical Nutrition, vol. 80, 6 Supplement, pp. 1689–1696, 2004. View at Google Scholar
  10. C. Lavie, J. Lee, and R. Milani, “Vitamin D and cardiovascular disease: will it live up to its hype?” Journal of the American College of Cardiology, vol. 58, no. 15, pp. 1547–1556, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Fry and T. Sanders, “Vitamin D and risk of CVD: a review of the evidence,” The Proceedings of the Nutrition Society, vol. 74, no. 3, pp. 245–257, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. A. L. Carrelli, M. D. Walker, H. Lowe et al., “Vitamin D deficiency is associated with subclinical carotid atherosclerosis: the Northern Manhattan study,” Stroke; a Journal of Cerebral Circulation, vol. 42, no. 8, pp. 2240–2245, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Chonchol, M. Cigolini, and G. Targher, “Association between 25-hydroxyvitamin D deficiency and cardiovascular disease in type 2 diabetic patients with mild kidney dysfunction,” Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association, vol. 23, no. 1, pp. 269–274, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Brøndum-Jacobsen, M. Benn, G. B. Jensen, and B. G. Nordestgaard, “25-hydroxyvitamin D levels and risk of ischemic heart disease, myocardial infarction, and early death: population-based study and meta-analyses of 18 and 17 studies,” Arteriosclerosis, Thrombosis and Vascular Biology, vol. 32, no. 11, pp. 2794–2802, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Blondon, M. Sachs, A. N. Hoofnagle et al., “25-Hydroxyvitamin D and parathyroid hormone are not associated with carotid intima-media thickness or plaque in the multi-ethnic study of atherosclerosis,” Arteriosclerosis, Thrombosis and Vascular Biology, vol. 33, no. 11, pp. 2639–2645, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. R. N. Foley, A. J. Collins, A. Ishani, and P. A. Kalra, “Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) Study,” American Heart Journal, vol. 156, no. 3, pp. 556–563, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Hioki, Y. Miyashita, T. Shiraki et al., “Impact of deteriorated calcium-phosphate homeostasis on amputation-free survival after endovascular revascularization in patients with critical limb ischemia on hemodialysis,” Vascular Medicine, vol. 21, no. 2, pp. 137–143, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Komaba and M. Fukagawa, “Phosphate-a poison for humans?” Kidney International, vol. 90, no. 4, pp. 753–763, 2016. View at Publisher · View at Google Scholar
  19. S. Shin, K. J. Kim, H. J. Chang et al., “Impact of serum calcium and phosphate on coronary atherosclerosis detected by cardiac computed tomography,” European Heart Journal, vol. 33, no. 22, pp. 2873–2881, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. R. C. Shroff, R. McNair, J. N. Skepper et al., “Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification,” Journal of the American Society of Nephrology, vol. 21, no. 1, pp. 103–112, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Yasin, D. Liu, L. Chau, J. Madrenas, and G. Filler, “Fibroblast growth factor-23 and calcium phosphate product in young chronic kidney disease patients: a cross-sectional study,” BMC Nephrology, vol. 14, p. 39, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. G. A. Block, T. E. Hulbert-Shearon, N. W. Levin, and F. K. Port, “Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study,” American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation, vol. 31, no. 4, pp. 607–617, 1998. View at Google Scholar
  23. J. Sanahuja, N. Alonso, J. Diez et al., “Increased burden of cerebral small vessel disease in patients with type 2 diabetes and retinopathy,” Diabetes Care, vol. 39, no. 9, pp. 1614–1620, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. M. F. Holick, N. C. Binkley, H. A. Bischoff-Ferrari et al., “Evaluations, treatment and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline,” The Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 7, pp. 1911–1930, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Vioque, E. M. Navarrete-Muñoz, D. Gimenez-Monzó et al., “Reproducibility and validity of a food frequency questionnaire among pregnant women in a Mediterranean area,” Nutrition Journal, vol. 12, p. 26, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. US Department of Agriculture: Agricultural Research Service, “USDA national nutrient database for standard reference,” 2015, http://ndb.nal.usda.gov/. View at Google Scholar
  27. M. S. Bernstein, A. Morabia, and D. Sloutskis, “Definition and prevalence of sedentarism in an urban population,” American Journal of Public Health, vol. 89, no. 6, pp. 862–867, 1999. View at Google Scholar
  28. P. J. Touboul, M. G. Hennerici, S. Meairs et al., “Mannheim carotid intima-media thickness consensus (2004–2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006,” Cerebrovascular Diseases, vol. 23, no. 1, pp. 75–80, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. M. V. Arcidiacono, A. Traveset, E. Rubinat et al., “Microangiopathy of large artery wall: a neglected complication of diabetes mellitus,” Atherosclerosis, vol. 228, no. 1, pp. 142–147, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. R Development Core Team R, A Language and Environment for Statistical Computing, R Foundation for Statistical Computing, Vienna Austria, 2016.
  31. A. Betriu, M. Martinez-Alonso, M. V. Arcidiacono et al., “Prevalence of subclinical atheromatosis and associated risk factors in chronic kidney disease: the NEFRONA study,” Nephrology Dialysis Transplantation, vol. 29, no. 7, pp. 1415–1422, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. R. H. Chen, X. Z. Jiang, Q. Jiang et al., “Correlations between serum levels of 25-hydroxyvitamin D and carotid atherosclerosis in patients with type 2 diabetes in Shanghai,” Annales d'Endocrinologie, vol. 75, no. 4, pp. 206–212, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Hao, X. Ma, Y. Luo et al., “Inverse association of serum vitamin D in relation to carotid intima-media thickness in Chinese postmenopausal women,” PLoS One, vol. 10, no. 3, article e0122803, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. J. S. McNally, T. M. Burton, B. W. Aldred et al., “Vitamin D and vulnerable carotid plaque,” American Journal of Neuroradiology, vol. 37, no. 11, pp. 2092–2099, 2016. View at Publisher · View at Google Scholar · View at Scopus
  35. I. Vinagre, M. Mata-Cases, E. Hermosilla et al., “Control of glycemia and cardiovascular risk factors in patients with type 2 diabetes in primary care in Catalonia (Spain),” Diabetes Care, vol. 35, no. 4, pp. 774–779, 2012. View at Publisher · View at Google Scholar · View at Scopus